Clinical Trial Update: Quetiapine in Specific Phobia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating quetiapine for specific phobia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Specific Phobia

Drugs mentioned

• Quetiapine (quetiapine)

Snippet

Sponsor: University Hospital Muenster | Conditions: Specific Phobia | Phase 2 | Status: COMPLETED